Search for Stocks /

Ajanta Pharma’s FY25 Profit Stands at ₹209 Cr, EPS ₹35.86 — Safe Bet or Just Boring Pharma Now?


📌 At a Glance

  • Revenue from Operations: ₹3,885.6 Cr
  • Other Income: ₹30.2 Cr
  • Total Income: ₹3,915.8 Cr
  • Net Profit: ₹209 Cr
  • EPS: ₹35.86
  • Tax Paid: ₹75.8 Cr
  • Debt-to-Equity: Just 0.0008 🤏
  • DSCR: 0.0069 😬
  • ISCR: 0.1672 😅

👉 Translation: Balance sheet = Yoga guru. Cash flows = Gym dropout.


🧬 About the Company

Ajanta Pharma Ltd is a Mumbai-based pharmaceutical company that produces, markets, and exports generics and branded formulations in over 30 countries. Its portfolio spans dermatology, ophthalmology, cardiology, and pain management.

They don’t chase trends like GLP-1 or AI. They just quietly mint money like your neighbourhood chemist who always has “stock hai bhai, generic bhi milega.”


🧑⚖️ Key Managerial Personnel (FY25)

NameDesignation
Yogesh M. AgrawalManaging Director
Rajesh S. AgrawalJoint Managing
Read Full 16 Point breakdown. Continue reading →
Members get full access to every article.
Become a member
Already a member? Log in
Read Full 16 Point breakdown. Continue reading →